METTL3 mediates m6A methylation on lnc-CTHCC and IGF2BP1/IGF2BP3 then recognizes the m6A modification, which maintains lnc-CTHCC stability and increases its expression in HCC. Here, IGF2BP1 is linked to hepatocellular carcinoma.